IKT
Price
$2.00
Change
-$0.10 (-4.76%)
Updated
May 9 closing price
Capitalization
156.12M
INRLF
Price
$3.27
Change
+$0.45 (+15.96%)
Updated
May 1 closing price
Capitalization
555.05M
Ad is loading...

IKT vs INRLF

Header iconIKT vs INRLF Comparison
Open Charts IKT vs INRLFBanner chart's image
Inhibikase Therapeutics
Price$2.00
Change-$0.10 (-4.76%)
Volume$109.43K
Capitalization156.12M
Valneva SE
Price$3.27
Change+$0.45 (+15.96%)
Volume$1K
Capitalization555.05M
IKT vs INRLF Comparison Chart
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKT vs. INRLF commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a Hold and INRLF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (IKT: $2.00 vs. INRLF: $3.27)
Brand notoriety: IKT and INRLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 84% vs. INRLF: 120%
Market capitalization -- IKT: $156.12M vs. INRLF: $555.05M
IKT [@Biotechnology] is valued at $156.12M. INRLF’s [@Biotechnology] market capitalization is $555.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whileINRLF’s FA Score has 0 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • INRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, IKT is a better buy in the long-term than INRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 4 TA indicator(s) are bullish.

  • IKT’s TA Score: 4 bullish, 7 bearish.

Price Growth

IKT (@Biotechnology) experienced а -11.11% price change this week, while INRLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

IKT is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($555M) has a higher market cap than IKT($156M). INRLF YTD gains are higher at: 56.459 vs. IKT (-38.462). INRLF has higher annual earnings (EBITDA): 21.2M vs. IKT (-20.04M). INRLF has more cash in the bank: 156M vs. IKT (3.24M). IKT has less debt than INRLF: IKT (145K) vs INRLF (201M). INRLF has higher revenues than IKT: INRLF (159M) vs IKT (0).
IKTINRLFIKT / INRLF
Capitalization156M555M28%
EBITDA-20.04M21.2M-95%
Gain YTD-38.46256.459-68%
P/E RatioN/AN/A-
Revenue0159M-
Total Cash3.24M156M2%
Total Debt145K201M0%
FUNDAMENTALS RATINGS
INRLF: Fundamental Ratings
INRLF
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WILCX10.020.05
+0.50%
Wasatch Global Value Institutional
FMILX57.17N/A
N/A
Fidelity New Millennium
SVPIX95.61N/A
N/A
ProFunds Small Cap Value Inv
JEMQX9.54N/A
N/A
JHancock Emerging Markets Equity A
BDAUX27.36N/A
N/A
Baron Durable Advantage R6

INRLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, INRLF has been loosely correlated with VALN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INRLF jumps, then VALN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
VALN - INRLF
42%
Loosely correlated
+1.41%
IKT - INRLF
22%
Poorly correlated
-4.76%
IMMX - INRLF
21%
Poorly correlated
-2.56%
NBTX - INRLF
20%
Poorly correlated
+1.79%
VXRT - INRLF
20%
Poorly correlated
+3.10%
More